Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain. The Spanish Pseudomonas aeruginosa Study Group
- PMID: 10103217
- PMCID: PMC89243
- DOI: 10.1128/AAC.43.4.981
Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain. The Spanish Pseudomonas aeruginosa Study Group
Abstract
We carried out a nationwide study with all of the isolates of Pseudomonas aeruginosa collected in a week in 136 hospitals in Spain. The data on 1,014 isolates included resistance to the following antimicrobials: piperacillin-tazobactam, 7%; meropenem, 8%; amikacin, 9%; tobramycin, 10%; piperacillin, 10%; ticarcillin, 13%; imipenem, 14%; ceftazidime, 15%; cefepime, 17%; ciprofloxacin, 23%; aztreonam, 23%; ofloxacin, 30%; gentamicin, 31%. The most frequent serotypes were O:1 (25.1%), O:4 (21.6%), and O:11 (11.3%).
References
-
- Bonfiglio G, Carciotto V, Russo G, Stefani S, Schito G C, Debbia E, Nicoletti G. Antibiotic resistance in Pseudomonas aeruginosa: an Italian survey. J Antimicrob Chemother. 1998;41:307–310. - PubMed
-
- Cavallo J D, Leblanc F, Thabaut A, Gerp B. Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C: American Society for Microbiology; 1998. Susceptibility of Pseudomonas aeruginosa to nine antimicrobials: a 1997 French multicenter hospital survey, abstr. E-77; p. 191.
-
- Gilligan P. Pseudomonas and Burkholderia. In: Murray P R, Baron E J, Pfaller M A P, Tenover F C, Yolken R H, editors. Manual of clinical microbiology. Washington, D.C: American Society for Microbiology; 1995. pp. 509–519.
-
- Jarvis W R, Martone M. Predominant pathogens in hospital infections. J Antimicrob Chemother. 1992;29(Suppl. A):19–24. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
